Last updated: November 17, 2021
Sponsor: Shandong University
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
N/AClinical Study ID
NCT04264663
2019-SDU-QILU-G226
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients aged 18-70 with H. pylori infection.
- Patients with previous Helicobacter pylori eradication.
- Patients Allergic to Penicillin.
Exclusion
Exclusion Criteria:
- Patients treated with H2-receptor antagonist, PPI, bismuth and antibiotics in theprevious 4 weeks.
- Patients with gastrectomy, acute GI bleeding and advanced gastric cancer.
- Patients with known or suspected allergy to study medications.
- Currently pregnant or lactating.
- Inability to provide informed consent and other situations that could interfere withthe examination or therapeutic protocol.
Study Design
Total Participants: 250
Study Start date:
November 01, 2019
Estimated Completion Date:
December 30, 2022
Study Description
Connect with a study center
Qilu hospital
Jinan, Shandong 250000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.